Search research articles
Contact Us
Filters
Showing results (111-120 of 290) with videos related to
Page
of 29
Sort By:
ESC Heart Failure
|
October 16, 2020
Elevated plasma endothelin-1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure
Robert Zymliński, Radosław Sierpiński, Marco Metra, et al.
Stem Cells Translational Medicine
|
November 25, 2023
Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial
Satsuki Yamada, Jozef Bartunek, Thomas J Povsic, et al.
European Heart Journal
|
November 21, 2013
A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
Piotr Ponikowski, Veselin Mitrovic, Mikhail Ruda, et al.
Heart Failure Reviews
|
May 3, 2025
Obesity and inflammation in chronic and acute heart failure
Gad Cotter, Mark C Petrie, Javed Butler, et al.
European Journal of Heart Failure
|
August 10, 2005
Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short-term outcome
Nir Uriel, Guillermo Torre-Amione, Olga Milo, et al.
European Journal of Heart Failure
|
December 17, 2003
Improved regional left ventricular function after successful satellite cell grafting in rabbits with myocardial infarction
Alex Blatt, Dror Robinson, Gad Cotter, et al.
European Journal of Heart Failure
|
August 25, 2010
Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
Marco Metra, John R Teerlink, G Michael Felker, et al.
European Journal of Heart Failure
|
September 9, 2010
Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function
Piotr Ponikowski, Veselin Mitrovic, Christopher M O'Connor, et al.
Journal of Clinical Medicine
|
October 13, 2021
Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial
Koji Takagi, Bruno Levy, Antoine Kimmoun, et al.
Lancet (London, England)
|
March 31, 2009
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
John R Teerlink, Marco Metra, G Michael Felker, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 290) with videos related to
Sort By:
Page
of 29
ESC Heart Failure
|
October 16, 2020
Elevated plasma endothelin-1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure
Robert Zymliński, Radosław Sierpiński, Marco Metra, et al.
Stem Cells Translational Medicine
|
November 25, 2023
Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial
Satsuki Yamada, Jozef Bartunek, Thomas J Povsic, et al.
European Heart Journal
|
November 21, 2013
A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
Piotr Ponikowski, Veselin Mitrovic, Mikhail Ruda, et al.
Heart Failure Reviews
|
May 3, 2025
Obesity and inflammation in chronic and acute heart failure
Gad Cotter, Mark C Petrie, Javed Butler, et al.
European Journal of Heart Failure
|
August 10, 2005
Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short-term outcome
Nir Uriel, Guillermo Torre-Amione, Olga Milo, et al.
European Journal of Heart Failure
|
December 17, 2003
Improved regional left ventricular function after successful satellite cell grafting in rabbits with myocardial infarction
Alex Blatt, Dror Robinson, Gad Cotter, et al.
European Journal of Heart Failure
|
August 25, 2010
Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
Marco Metra, John R Teerlink, G Michael Felker, et al.
European Journal of Heart Failure
|
September 9, 2010
Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function
Piotr Ponikowski, Veselin Mitrovic, Christopher M O'Connor, et al.
Journal of Clinical Medicine
|
October 13, 2021
Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial
Koji Takagi, Bruno Levy, Antoine Kimmoun, et al.
Lancet (London, England)
|
March 31, 2009
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
John R Teerlink, Marco Metra, G Michael Felker, et al.
Page
of 29